States have responded to the slow rollout of coronavirus vaccine by expanding eligibility to people over 65. But that is making it more difficult to recruit subjects for clinical trials of other vaccines that have yet to win approval.
Trending:
Elderly begin to drop out of Novavax vaccine trial to get Pfizer and Moderna shots